Friday, November 15, 2024

The UN braces for Trump

Presented by GSK: The ideas and innovators shaping health care
Nov 15, 2024 View in browser
 
POLITICO Future Pulse Newsletter Header

By Carmen Paun, Erin Schumaker, Ruth Reader and Daniel Payne

Presented by 

GSK
WORLD VIEW

COXS BAZAR, BANGLADESH - SEPTEMBER 15: Rohingya are seen in an informal settlement September 15, 2017 in Cox's Bazar, Bangladesh. Nearly 400,000 Rohingya refugees have fled into Bangladesh since late August during the outbreak of violence in the Rakhine state as recent satellite images released by Amnesty International provided evidence that security forces were trying to push the minority Muslim group out of the   country. Myanmar's de facto leader Aung San Suu Kyi cancelled her trip to the United Nations General Assembly in New York, which begins next week, while criticism on her handling of the Rohingya crisis grows and her government has been accused of ethnic cleansing. According to reports, the Rohingya crisis has left at least 1,000 people dead, including children and infants, with dozens of the Rohingya Muslims who drowned when their boat capsized while trying to escape on overloaded fishing boats ill-equipped for rough waters. (Photo by Allison Joyce/Getty Images)

Refugees in Bangladesh depend on U.N. Population Fund aid. | Getty Images

The United Nations agency charged with improving reproductive and maternal health worldwide is bracing to lose its top government donor once President-elect Donald Trump returns to the White House next year.

The U.N. Population Fund — better known as UNFPA — has seen its funding cut by Republican presidents since 1986, and it expects Trump will do so again when he takes office on Jan. 20.

But its top representative in Washington hopes Trump will at least leave the door open for collaboration with U.S agencies such as the State Department and the U.S. Agency for International Development because they all share the same goals.

“We don’t want women to die in childbirth, we don’t want anyone to be terrorized by gender-based violence and we don’t want anyone to have their futures derailed by substandard health systems,” Sarah Craven, the UNFPA Washington office chief, told Carmen.

The backstory: Republican presidents have deemed UNFPA ineligible for U.S. funding because of its work in China, which for more than three decades required families to have only one child. This policy subjected women to forced contraception, sterilization and abortion, according to Human Rights Watch.

A provision Congress passed in 1985, called the Kemp-Kasten Amendment, barred U.S. funds from going to organizations deemed to support or participate in programs of coercive abortion or involuntary sterilization.

UNFPA was never proven to have done that, “it’s just because we have a program in China,” Craven said, pointing to reports from the U.S. and other governments about UNFPA’s work in China.

UNFPA also doesn’t provide or support abortion services. A perception that it does is another reason for Republicans to deny funding.

The organization provides women with sanitary and post-delivery kits in some of the world’s most conflict-ridden and impoverished regions, where women must sometimes face childbirth alone. It also offers access to condoms and contraceptive pills.

The Biden administration is expected to contribute about $181 million to UNFPA this year, a historic high. The U.S. was UNFPA’s top donor in 2022 and 2023.

“The prospect of losing the funding or that political-technical partnership is very daunting,” Craven said.

What’s next? If Trump proceeds with the cut, UNFPA says women would “lose lifesaving services in some of the world’s most devastating crises.”

That includes Bangladesh, where U.S. funding has helped provide maternal health care, family planning, gender-based violence prevention and response and emergency support to more than 200,000 women and girls living in the refugee camp in the Cox’s Bazar district and in host communities.

And 20 safe spaces offering mental health support to women traumatized by the Ukraine war and at increased risk of gender-based violence would have to close, among other consequences, according to UNFPA.

While other countries and donors have in the past increased their support to UNFPA to help make up for the shortfall caused by previous U.S. cuts, Craven said it would be tougher for many governments to do so this time, given tight budgets around the world.

 

A message from GSK:

Advertisement Image

 
WELCOME TO FUTURE PULSE

Gouldsboro, Maine

Gouldsboro, Maine | Shawn Zeller/POLITICO

This is where we explore the ideas and innovators shaping health care. 

Farm state lawmakers seemed concerned about President-elect Donald Trump's decision to nominate pesticide and food additive skeptic Robert F. Kennedy Jr. to lead HHS this week. Iowa GOP Sen. Chuck Grassley told our Ben Leonard: “Whatever ideas he has about making lives … more healthy, it’s got to be compromised with producing enough food so everyone doesn’t die."

Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com , or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

POLICY PUZZLE

Lina Khan, Chair of the Federal Trade Commission

Lina Khan's days at the FTC are likely numbered. | Kevin Dietsch/Getty Images

Donald Trump’s election victory could be the death knell for the Federal Trade Commission’s rule banning employment agreements that make it difficult for workers to quit and join rivals — and a win for hospitals who opposed the rule.

The FTC approved the ban on noncompete agreements for all workers, aside from senior executives in policymaking roles earning more than $151,164, in April in a 3-2 vote. But a Texas judge blocked the rule in the summer, ruling that the FTC had exceeded the agency’s authority. President Joe Biden’s FTC chair, Lina Khan, who aggressively pursued the ban, will likely resign or be replaced by Trump.

Once Republicans take charge of the FTC next year, it’s “very likely they would take the position that it’s not something the FTC has the authority to do on this scale,” Kevin Paule, an attorney at law firm Hill Ward Henderson who specializes in commercial litigation, told POLITICO.

Trump’s FTC could rescind the rule or decide to stop defending it in court.

Why it matters for health care: The FTC’s rule caused a rift in the health care sector, where a large share of doctors — 45 percent in group practices and likely many more in other areas of medicine — are bound by noncompetes.

Doctors argued that both they and their patients would benefit from a penalty-free job market, which would create a more efficient health care system and improve physician satisfaction.

Hospital administrators said the ban could harm patients who’d lose doctors they’d grown to know.

“The federal court in Texas made the right call in preventing the FTC’s flawed non-compete rule from taking effect,” Charlene MacDonald, executive vice president of public affairs at the Federation of American Hospitals, said in a statement. “We’re optimistic that the Trump Administration will take a market-based approach to ensuring patient access to care.”

The American Hospital Association, which also lobbied against the ban, declined to comment on Trump’s win.

In the states: California, Minnesota, North Dakota and Oklahoma have noncompete bans of one sort or another on the books, and other states are pursuing their own rules.

 

The lame duck session could reshape major policies before year's end. Get Inside Congress delivered daily to follow the final sprint of dealmaking on defense funding, AI regulation and disaster aid. Subscribe now.

 
 
WASHINGTON WATCH

WASHINGTON, DC - JULY 2: National Health Institute Director Francis S. Collins holds a model of a Coronavirus, as he testifies at a Senate Labor, Health and Human Services, Education and Related Agencies Subcommittee hearing on manufacturing a Coronavirus vaccine on Capitol Hill on July 2, 2020 in Washington, DC. (Photo by Graeme Jennings-Pool/Getty Images)

Francis Collins led the National Institutes of Health during the Covid pandemic. | Getty Images

The effect of President-elect Donald Trump's decision to nominate anti-vaccine activist and environmental lawyer Robert F. Kennedy Jr. as secretary of Health and Human Services has prompted hand wringing within the scientific community.

RFK Jr.'s views about vaccines and other public health measures directly conflict with scientific evidence. But they're appealing to an increasingly science-skeptical population scientists are trying to win back.

Former National Institutes of Health Director Francis Collins spoke to that dynamic at the Milken Institute Future of Health Summit in Washington Thursday.

The election results indicate that the majority of the country wants a change in leadership, Collins said, and those people likely hold views that are different from many in the scientific community.

Trust by the numbers: Public trust in science and scientists eroded during the pandemic and never fully recovered. According to a Pew survey published this week:

— 52 percent of respondents didn't think research scientists were good communicators

— 47 percent said research scientists felt superior to others

Collins thinks scientists should work to understand the skeptics.

"Not that we should be compromising in any way about truth, but understanding how other people can arrive at different conclusions — that's going to be a critical part of this," he said of restoring trust in science.

Scientists also have to be willing to admit it when they make mistakes, Collins said, adding that he wished he'd been more candid with the public when giving public health guidance during the pandemic: "I should have said every time, here's the best information we have today, but it's very incomplete. You're watching science develop in real time," he said.

"We didn't say that enough and we lost people's confidence along the way."

 

Policy change is coming—be the pro who saw it first. Access POLITICO Pro’s Issue Analysis series on what the transition means for agriculture, defense, health care, tech, and more. Strengthen your strategy.

 
 
 

Follow us on Twitter

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

No comments:

Post a Comment

Top 5 Stocks About to Test Their 52-Week Low

A 52-week low is a technical indicator used by some of the world's top traders and investors to determine the current and ...